2.35
Precedente Chiudi:
$2.27
Aprire:
$2.3
Volume 24 ore:
141.40K
Relative Volume:
1.10
Capitalizzazione di mercato:
$130.57M
Reddito:
-
Utile/perdita netta:
$-21.38M
Rapporto P/E:
-6.0256
EPS:
-0.39
Flusso di cassa netto:
$-25.19M
1 W Prestazione:
+26.34%
1M Prestazione:
+145.89%
6M Prestazione:
+138.58%
1 anno Prestazione:
+74.07%
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Company Profile
Nome
Connect Biopharma Holdings Ltd Adr
Settore
Industria
Telefono
858-727-1040
Indirizzo
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
Confronta CNTB con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
CNTB
Connect Biopharma Holdings Ltd Adr
|
2.35 | 132.24M | 0 | -21.38M | -25.19M | -0.39 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-06-12 | Iniziato | H.C. Wainwright | Buy |
2024-03-04 | Iniziato | H.C. Wainwright | Buy |
2021-04-13 | Iniziato | Jefferies | Buy |
2021-04-13 | Iniziato | Piper Sandler | Overweight |
2021-04-13 | Iniziato | SVB Leerink | Outperform |
Connect Biopharma Holdings Ltd Adr Borsa (CNTB) Ultime notizie
Connect Biopharma Shares Rise on Plan to End ADR Program and Directly List on Nasdaq - MSN
Connect Biopharma stock rating reiterated as Outperform by Northland - Investing.com India
Connect Biopharma appoints Jim Schoeneck to board of directors By Investing.com - Investing.com South Africa
Connect Biopharma appoints James A. Schoeneck to board of directors By Investing.com - Investing.com Nigeria
Connect Biopharma stock rises after announcing plan to terminate ADR program - Investing.com
Connect Biopharma to terminate ADR program, list ordinary shares By Investing.com - Investing.com Nigeria
Connect Biopharma to terminate ADR program, list ordinary shares - Investing.com
Connect Biopharma to Terminate ADR Program and List Ordinary Shares on Nasdaq - Nasdaq
Connect Biopharma Announces Plans to Terminate its American - GlobeNewswire
Connect Biopharma Streamlines Trading: ADRs Convert to Direct Nasdaq Shares in Major US Market Push - Stock Titan
Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewswire Inc.
Connect Biopharma regains Nasdaq compliance with minimum bid price rule By Investing.com - Investing.com India
Connect Biopharma regains Nasdaq compliance with minimum bid price rule - Investing.com
Connect Biopharma regains Nasdaq compliance with $1 minimum bid price - Investing.com
Connect Biopharma’s partner submits new drug application in China - Investing.com
Connect Biopharma (NASDAQ:CNTB) Trading Down 2.5% – Here’s What Happened - Defense World
Connect Biopharma reports positive data for asthma treatment By Investing.com - Investing.com South Africa
Connect Biopharma reports positive data for asthma treatment - Investing.com
Connect Biopharma begins Phase 2 asthma study - Investing.com
Connect Biopharma stock hits 52-week low at $0.55 amid market challenges By Investing.com - Investing.com South Africa
Connect Biopharma stock hits 52-week low at $0.55 amid market challenges - Investing.com
FDA greenlights Connect Biopharma’s asthma and COPD trials - Investing.com
Connect Biopharma stock holds $8 target, Buy rating at H.C. Wainwright - Investing.com
Connect Biopharma faces Nasdaq delisting over share price By Investing.com - Investing.com India
Connect Biopharma faces Nasdaq delisting over share price - Investing.com
Connect Biopharma stock hits 52-week low at $0.76 - Investing.com
Connect Biopharma stock hits 52-week low at $0.91 amid market challenges - Investing.com India
Form N-CSR FIDELITY CONCORD STREET For: Nov 30 - StreetInsider.com
Top 3 Aerospace and Defense Stocks Flying Under the Radar - The Globe and Mail
CPIX Stock Quote Price and Forecast - CNN
Is Connect Biopharma Holdings (CNTB) Stock Outpacing Its Medical Peers This Year? - Nasdaq
Stocks Set to Open Lower as Investors Await Fed Meeting, Banking Sector Remains in Focus - Barchart.com
What should you do if you own US-listed Chinese stocks ordered by SEC to delist? - Dr Wealth
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
Making it harder to "buy" China, Inc. - USC-China Institute
ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire
CNTB News Today | Why did Connect Biopharma stock drop today? - MarketBeat
Connect Biopharma (CNTB) Stock Price, News & Analysis - MarketBeat
Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time - MarketBeat
52 Week HighUnited States Stocks - Investing.com
Connect Biopharma Holdings Ltd Adr Azioni (CNTB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):